Search Results
Soff: Rivaroxaban for Cancer-Associated VTE
Quality assessment looking at rivaroxaban for cancer-related thrombosis
Rivaroxaban reduces burden of cancer-associated venous thromboembolic disease
Improving Quality of VTE Care
Cancer and VTE: What's the Connection?
Updates in the Management of Cancer Associated Thrombosis
Cancer-associated thrombosis: 6 months and beyond. Presented by: Dr Vickie McDonald
Guidance for anticoagulation management in the setting of thrombocytopenia in cancer patients
Thrombosis Management in Oncology Patients
Estudio XALIA: Rivaroxaban vs terapia anticoagulante convencional en la práctica clínica cotidiana
ACC 2020: Apixaban for behandling av venøs tromboemboli forbundet med kreft
2023 Updates in Anticoagulation
